ArticleBMC cancer2023

Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity.

Yuan-Xiang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.